Infinitt Healthcare Co., Ltd(KR:071200)
â‚©10,420.00-240.00 (-2.25%)
KR:071200
Infinitt Healthcare Co., Ltd financials statements
â‚©10,420.00
At close:-240.00 (-2.25%)
Infinitt Healthcare Co., Ltd (071200) Ratios
Infinitt Healthcare Co., Ltd Ratios
KR:071200's free cash flow for Q2 2025 was ₩4.34B. For the 2025 fiscal year, KR:071200's free cash flow was decreased by ₩-41.15M and operating cash flow was ₩4.39B. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.68 | 4.24 | 3.91 | 4.10 | 3.30 |
| Quick Ratio | 4.66 | 4.19 | 3.84 | 4.05 | 3.19 |
| Cash Ratio | 0.37 | 0.41 | 1.08 | 0.48 | 1.47 |
| Solvency Ratio | 0.90 | 0.53 | 0.08 | 0.82 | 0.31 |
| Operating Cash Flow Ratio | 0.30 | 0.31 | 0.30 | 0.58 | 0.62 |
| Short-Term Operating Cash Flow Coverage | 14.09 | 11.60 | 9.22 | 12.21 | 13.62 |
| Net Current Asset Value | â‚© 136.88B | â‚© 101.05B | â‚© 78.55B | â‚© 81.27B | â‚© 57.34B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.31 | 1.30 | 1.27 | 1.31 |
| Debt Service Coverage Ratio | 50.28 | 21.77 | 2.65 | 17.64 | 6.74 |
| Interest Coverage Ratio | 105.43 | 49.57 | 63.14 | 105.48 | 52.27 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 147.29 | 157.30 | 165.25 | 153.96 | 159.57 |
| Net Debt to EBITDA | -0.20 | -0.38 | 65.75 | -0.33 | -3.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 63.90% | 59.57% | 61.53% | 59.49% | 62.32% |
| EBIT Margin | 53.51% | 25.62% | -3.37% | 33.44% | 12.06% |
| EBITDA Margin | 56.07% | 28.34% | -0.47% | 36.46% | 15.10% |
| Operating Profit Margin | 13.68% | 7.20% | 8.71% | 15.95% | 10.40% |
| Pretax Profit Margin | 53.39% | 25.48% | -3.51% | 33.29% | 11.86% |
| Net Profit Margin | 43.24% | 20.80% | 0.15% | 28.98% | 9.54% |
| Continuous Operations Profit Margin | 45.99% | 22.05% | 0.18% | 28.96% | 9.52% |
| Net Income Per EBT | 81.00% | 81.63% | -4.25% | 87.06% | 80.40% |
| EBT Per EBIT | 390.36% | 353.68% | -40.25% | 208.78% | 114.12% |
| Return on Assets (ROA) | 18.90% | 10.94% | 0.09% | 15.76% | 5.59% |
| Return on Equity (ROE) | 24.69% | 14.28% | 0.11% | 19.94% | 7.33% |
| Return on Capital Employed (ROCE) | 7.23% | 4.69% | 6.38% | 10.70% | 7.79% |
| Return on Invested Capital (ROIC) | 6.16% | 3.84% | -0.33% | 9.10% | 6.10% |
| Return on Tangible Assets | 18.98% | 11.02% | 0.09% | 15.90% | 5.64% |
| Earnings Yield | 39.54% | 15.85% | 0.09% | 12.96% | 3.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.05 | 3.10 | 2.97 | 2.93 | 2.60 |
| Payables Turnover | 8.96 | 6.36 | 7.16 | 7.72 | 5.68 |
| Inventory Turnover | 43.58 | 19.97 | 16.80 | 21.93 | 9.64 |
| Fixed Asset Turnover | 5.22 | 4.62 | 3.31 | 2.99 | 2.75 |
| Asset Turnover | 0.44 | 0.53 | 0.59 | 0.54 | 0.59 |
| Working Capital Turnover Ratio | 0.79 | 0.95 | 1.05 | 1.08 | 1.25 |
| Cash Conversion Cycle | 57.81 | 78.46 | 93.76 | 93.85 | 113.84 |
| Days of Sales Outstanding | 90.15 | 117.60 | 123.01 | 124.49 | 140.20 |
| Days of Inventory Outstanding | 8.38 | 18.28 | 21.73 | 16.64 | 37.87 |
| Days of Payables Outstanding | 40.72 | 57.43 | 50.98 | 47.29 | 64.23 |
| Operating Cycle | 98.53 | 135.88 | 144.74 | 141.13 | 178.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 494.53 | 420.23 | 332.62 | 653.77 | 662.35 |
| Free Cash Flow Per Share | 479.80 | 390.73 | 312.66 | 616.49 | 608.08 |
| Dividend Paid and CapEx Coverage Ratio | 33.58 | 14.24 | 16.67 | 17.54 | 12.20 |
| Capital Expenditure Coverage Ratio | 33.58 | 14.24 | 16.67 | 17.54 | 12.20 |
| Operating Cash Flow Coverage Ratio | 3.49 | 2.77 | 2.07 | 4.38 | 4.30 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.11 | 0.10 | 0.20 | 0.23 |
| Free Cash Flow Yield | 10.48% | 7.87% | 5.70% | 8.60% | 8.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 2.53 | 6.31 | 1098.00 | 7.72 | 25.11 |
| Price-to-Sales (P/S) Ratio | 1.09 | 1.31 | 1.64 | 2.24 | 2.39 |
| Price-to-Book (P/B) Ratio | 0.62 | 0.90 | 1.25 | 1.54 | 1.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.55 | 12.71 | 17.56 | 11.63 | 11.31 |
| Price-to-Operating Cash Flow Ratio | 9.26 | 11.81 | 16.51 | 10.97 | 10.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.00 | -11.04 | 0.03 | -3.24 |
| Enterprise Value Multiple | 1.75 | 4.25 | -284.11 | 5.80 | 12.60 |
| Enterprise Value | 99.79B | 110.80B | 117.31B | 165.42B | 133.32B |
| EV to EBITDA | 1.75 | 4.25 | -284.11 | 5.80 | 12.60 |
| EV to Sales | 0.98 | 1.20 | 1.33 | 2.12 | 1.90 |
| EV to Free Cash Flow | 8.58 | 11.66 | 14.26 | 11.00 | 8.99 |
| EV to Operating Cash Flow | 8.32 | 10.84 | 13.40 | 10.37 | 8.25 |
| Tangible Book Value Per Share | 7414.66 | 5460.08 | 4316.40 | 4591.40 | 3681.71 |
| Shareholders’ Equity Per Share | 7335.56 | 5509.03 | 4375.26 | 4659.75 | 3737.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.17 | 1.05 | 0.13 | 0.20 |
| Revenue Per Share | 4187.94 | 3782.71 | 3355.15 | 3205.26 | 2872.84 |
| Net Income Per Share | 1811.05 | 786.75 | 5.00 | 929.00 | 274.00 |
| Tax Burden | 0.81 | 0.82 | -0.04 | 0.87 | 0.80 |
| Interest Burden | 1.00 | 0.99 | 1.04 | 1.00 | 0.98 |
| Research & Development to Revenue | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 |
| SG&A to Revenue | 0.12 | 0.12 | 0.10 | 0.09 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.27 | 0.52 | 54.39 | 0.70 | 2.42 |
Currency in KRW

